Search Results 1581-1590 of 21424 for platelets

1. Sacroiliitis - Doctors and departments - Mayo Clinic

   ... Platelet rich plasma injection, Intramuscular injection, Joint examination, Ultrasound-guided musculoskeletal injection, Musculoskeletal exam, Nerve ...

2. Cryoprobe Biopsy in Chronic Rejection in Lung Transplant Recipients - Mayo Clinic

   Platelet count <50,000 per μL within 14 days of the biopsy procedure; Current use of systemic anticoagulation or antiplatelet therapy without the ability to ...

3. Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Platelets (PLT) >= 100,000 / uL; Hemoglobin (HgB) >= 9.0 g/dL; Total bilirubin =< 1.5 x upper normal limit (UNL); Serum glutamic oxaloacetic transaminase (SGOT) ...

4. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Platelets ≥ 100 K/microliter; Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min using the Cockcroft-Gault ...

5. A Study to Compare ACP-196 and Obinutuzumab with Chlorambucil, or ACP-19 alone, with Obinutuzumab and Chlorambucil, for Patients with Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Platelet count ≥ 50,000 cells/μL, or ≥ 30,000 cells/μL with documented bone marrow involvement, and without transfusion support 7 days before assessment.

6. Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Platelets ≥ 75,000/mm^3; Hemoglobin ≥ 8.0 g/dL (the use of transfusion or other intervention is allowed); Serum alanine aminotransferase (ALT) and aspartate ...

7. Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo Clinic co-led phase I study

   The drug appeared to be safe at its highest doses of 3 mg/kg, with rash and decreased platelet counts being the most common drug-related adverse events. The ...

8. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

   International normalized ratio (INR) above 1.0 × ULN. Platelet count below 100 × 103/µL; Presence of clinically significant hepatic decompensation, including ...

9. Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates - Mayo Clinic

   Patients must have adequate bone marrow function: - Platelets >100,000 cells/mm3 - Hemoglobin > 9.0 g/dL - Absolute Neutrophil Count > 1,500 cells/mm3 ...

10. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma - Mayo Clinic

    Platelet count ≥ 75,000/uL; abnormal blood counts are permissible if there is bone marrow biopsy or aspirate proven bone marrow involvement by rhabdomyosarcoma ...